iCAD INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 21 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-12-07: Reporting owner SASSINE ANDY; Form 4; Security Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-04-09: Reporting owner SUSSMAN ELLIOT J MD MBA; Form 4; Security Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-03-23: Reporting owner Ecock Anthony F; Form 4; Security Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-02-10: Reporting owner Stevens Stacey M; Form 4; Security Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-12-07 | SASSINE ANDY Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,358 5,358 owned after | $4.01 | 2015-12-09 | |
| 2015-04-09 | SUSSMAN ELLIOT J MD MBA Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $9.05 exercise price | 2015-04-09 | |
| 2015-03-23 | Ecock Anthony F Director | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $9.05 exercise price | 2015-03-25 | |
| 2015-02-10 | Stevens Stacey M Officer (SVP Marketing & Strategy) | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,298 0 owned after | $5.75 exercise price | 2015-02-11 | |
| 2015-02-10 | Stevens Stacey M Officer (SVP Marketing & Strategy) | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 10,000 owned after | $5.10 exercise price | 2015-02-11 | |
| 2015-02-05 | Stevens Stacey M Officer (SVP Marketing & Strategy) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $9.00 exercise price | 2015-02-09 | |
| 2015-02-05 | Go Jonathan Officer (SVP Research and Development) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,500 12,500 owned after | $9.00 exercise price | 2015-02-09 | |
| 2015-02-05 | Ferry Kenneth M Director, Officer (CEO) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $9.00 exercise price | 2015-02-09 | |
| 2015-02-05 | Burns Kevin C Officer (President/ CFO/ COO) | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $9.00 exercise price | 2015-02-09 | |
| 2015-01-20 | Subramaniam Somu Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $9.00 exercise price | 2015-01-22 | |
| 2015-01-20 | SUSSMAN ELLIOT J MD MBA Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $9.00 exercise price | 2015-01-22 | |
| 2015-01-20 | RAPPAPORT STEVEN N Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $9.00 exercise price | 2015-01-22 | |
| 2015-01-20 | Brem Rachel Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,281 1,281 owned after | $9.00 exercise price | 2015-01-22 | |
| 2015-01-20 | Brem Rachel Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $9.00 exercise price | 2015-01-22 | |
| 2015-01-20 | HOWARD DR LAWRENCE Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $9.00 exercise price | 2015-01-22 | |
| 2015-01-20 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,718 0 owned after | $7.45 exercise price | 2015-01-22 | |
| 2015-01-20 | Ecock Anthony F Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $9.00 exercise price | 2015-01-22 | |
| 2015-01-20 | Goodman Robert L Director | 4 | Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $9.00 exercise price | 2015-01-22 | |
| 2015-01-16 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $7.45 exercise price | 2015-01-21 | |
| 2015-01-15 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,123 0 owned after | $7.45 exercise price | 2015-01-21 | |
| 2015-01-06 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $7.45 exercise price | 2015-01-08 |